Edwards Lifesciences (EW) PT Lowered to $80 at Wells Fargo

Go back to Edwards Lifesciences (EW) PT Lowered to $80 at Wells Fargo

Edwards Lifesciences (EW) PT Lowered to $80 at Barclays

September 9, 2024 6:54 AM EDT

Barclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.

The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More

Edwards Lifesciences (EW) PT Lowered to $80 at Barclays

September 9, 2024 6:54 AM EDT

Barclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.

The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More